NDA, MAA Remain Key Focal Points for Celator Pharma (CPXX) Moving Forward; Roth Affirms at 'Buy'

Go back to NDA, MAA Remain Key Focal Points for Celator Pharma (CPXX) Moving Forward; Roth Affirms at 'Buy'

Form 8-K Celator Pharmaceuticals For: Mar 21

March 21, 2016 9:29 AM EDT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

CURRENT REPORT

... More

Form 10-K Celator Pharmaceuticals For: Dec 31

March 21, 2016 9:22 AM EDT

... More